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2
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Abstract
Prion proteins can adopt multiple different infectious strain conformations. Here we examine how 
the sequence of a prion protein affects its capacity to propagate specific conformations by 
exploiting our ability to create two distinct infectious conformations of the yeast [PSI+] prion 
protein Sup35p, termed Sc4 and Sc37. PNM2, a Sup35p (G58D) point mutant originally identified 
for its dominant interference with prion propagation, leads to rapid, recessive loss of Sc4 but does 
not interfere with Sc37 propagation. PNM2 destabilizes the amyloid core of Sc37 causing 
compensatory effects that slow prion growth but aid prion division and result in robust Sc37 
propagation. In contrast, PNM2 does not affect the structure or chaperone-mediated division of 
Sc4, but interferes with its delivery to daughter cells. Thus, effective delivery of infectious 
particles during cell division is a critical and conformation-dependent step in prion inheritance.
Introduction
Infectious proteins, or prions, are a form of conformation-based inheritance, in which a 
prion protein aggregate binds to and catalyzes the conversion of newly-made proteins to the 
prion form creating stably propagating states1. Such conformation-based inheritance 
underlies a range of transmissible spongiform encephalopathies in mammals as well as 
heritable epigenetic states in fungi, of which the yeast Saccharomyces cerevisiae prion 
[PSI+] is arguably the best characterized2. A common feature of prion proteins is that they 
misfold into ordered, β-sheet rich amyloid fibers, the self-templating nature of which is 
thought to form the basis of prion propagation1,3. Remarkably, a single prion protein can 
adopt a spectrum of amyloid conformations that lead to different, heritable strain variants4–
11
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The yeast prion [PSI+], which results from the aggregation of the translation termination 
factor Sup35p, has emerged as a powerful system for studying strain variants. Sup35p can 
form different amyloid conformations in vitro when polymerized at 4 °C versus 37 °C8,12,13. 
When introduced into yeast, these amyloid fibers form two distinct strains in vivo termed 
[PSI+]Sc4 and [PSI+]Sc37, respectively. (For clarity, we use [PSI+]Sc4 to describe the in vivo 
strain and Sc4 to describe the fiber conformation.) These strains are distinguished by the 
degree of Sup35p aggregation: [PSI+]Sc4 yeast exhibit a strong prion phenotype, in which 
the large majority of Sup35p is aggregated, while [PSI+]Sc37 yeast have a more substantial 
pool of soluble Sup35p and a weaker prion phenotype. Structural studies revealed that there 
is a dramatic expansion of the amyloid core in the Sc37 conformation relative to that found 
in Sc414,15. The more extensive structure in Sc37 fibers increases fiber stability and 
decreases the rate of prion replication by the cell’s chaperone system resulting in the weaker 
[PSI+]Sc37 prion phenotype16. The ability to probe the biophysical properties of these 
defined strain variant conformations in vitro and monitor their phenotypes in vivo makes 
[PSI+] an excellent system for the study of prion strain phenomena.
The precise amino acid sequence greatly biases the ability of a prion protein to adopt 
particular strain variants7,17–19. For example, the naturally occurring methionine/valine 
polymorphism at position 129 of the mammalian prion protein greatly influences disease 
susceptibility20. The Val129 allele does not interfere with the propagation of all prion strain 
variants and may even favor some, including certain iatrogenic forms of Creutzfeldt-Jakob 
diease19. However, the presence of even a single allele of Val129 appears to be highly 
protective against developing new variant Creutzfeldt-Jakob disease (nvCJD)21, which is 
thought to result from transmission of bovine spongiform encephalopathy (mad cow disease) 
to humans22,23.
This strong relationship between strain variants and the sequence of the prion protein 
extends to the [PSI+] prion system. A mutant of the Sup35p prion protein, which was 
originally identified in a screen for “Psi no more” mutants that prevented propagation of 
[PSI+], shows strain variant-specific effects. This mutant, termed PNM2, has a glycine to 
aspartate missense mutation at amino acid position 5824. Originally, the effect of PNM2 was 
described as causing dominant inhibition of prion propagation when co-expressed with wild 
type Sup35p24,25. Later studies found that PNM2 does not interfere with propagation of all 
[PSI+] strain variants and may enhance propagation of certain strain variants when 
overexpressed17.
Here, we used the PNM2 mutant and the well-defined prion strain conformations, Sc4 and 
Sc37, together with in-depth biophysical and in vivo analyses, to investigate how point 
mutations can affect prion propagation in a manner that depends on the strain variant. Our 
systematic characterization of fiber structure, chaperone-mediated division of fibers into 
seeds and delivery of seeds to daughter cells reveals a PNM2-specific defect in seed 
partitioning for the [PSI+]Sc4 strain variant. The findings implicate delivery of fiber seeds to 
daughter buds as a critical step in prion propagation.
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Results
PNM2 shows strain-specific effects on [PSI+] propagation
We began by characterizing the effect of the PNM2 mutation on prion propagation in 
[PSI+]Sc4 and [PSI+]Sc37 yeast. To allow for rapid exchange of alleles, we used a yeast 
background in which the genomic copy of SUP35 was deleted and replaced by a copy on a 
plasmid containing the counter-selectable URA3 marker. We exchanged this plasmid with 
one encoding wild-type Sup35p (WT) or Sup35p G58D (PNM2) and confirmed that the two 
proteins were expressed at similar levels (Fig. 1a). We assessed the prion phenotype with a 
red/white color readout that results from suppression of a nonsense mutation in an ADE1 
reporter (the ade1–14 allele)26. When Sup35p is soluble ([psi−]), translation of ade1–14 
terminates prematurely, resulting in accumulation of a red metabolic intermediate. When 
Sup35p is aggregated ([PSI+]), read-through of the nonsense mutation occurs and functional 
Ade1p is produced. Depending on the amount of soluble Sup35p present and perhaps the 
nature of the aggregates, [PSI+] strain variants have varying levels of functional Ade1p and 
exhibit color phenotypes ranging from pink ([PSI+]Sc37) to white ([PSI+]Sc4) (Fig. 1b). This 
assay also reports on the stability of prion inheritance: when a cell in a growing colony loses 
[PSI+], its progeny remain prion free and form a red sector (Fig. 1c).
Using the [PSI+]Sc4 and [PSI+]Sc37 yeast backgrounds, we found that PNM2 has dramatic, 
strain variant-specific effects on prion propagation. When expressed as the sole copy of 
Sup35p, PNM2 strongly compromised propagation of [PSI+]Sc4, apparent by the continuous 
generation of prion-free ([psi−]) states (Fig. 1b,c,d). This effect is similar to the originally 
reported description of the PNM2 phenotype24,25, though there are differences between 
studies: PNM2 is recessive in our strain background and thus does not strongly interfere 
with [PSI+]Sc4 propagation when co-expressed with WT (Fig. 1b). Thus, we focused on 
analyzing effects of prion propagation when PNM2 is expressed as the sole copy of Sup35p.
In contrast to its dramatic effect on [PSI+]Sc4 propagation, PNM2 had a much weaker effect 
on propagation of the [PSI+]Sc37 strain variant, with at most a mild darkening of the color 
phenotype and no discernable increase in prion loss (Fig. 1b,d). This result was surprising 
given that previous studies indicate that the PNM2 mutation is located in a region that is 
structured in Sc37 but not in Sc415, leading to the expectation that the PNM2 mutation 
would preferentially interfere with propagation of the Sc37 conformation.
We first asked whether the defect in stable inheritance seen in [PSI+]Sc4 yeast could arise 
from the PNM2 mutation forcing an irreversible structural change that results in an amyloid 
conformation that is poorly propagated. We carried out a series of plasmid exchanges, 
replacing the WT plasmid with the PNM2 plasmid, then exchanging it back with the WT 
plasmid. Reintroduction of the WT plasmid fully restored the original [PSI+]Sc4 phenotype 
(Fig. 1e), indicating that the PNM2 Sc4 fibers retained the structural information necessary 
to template WT to the characteristic Sc4 amyloid conformation.
To investigate what accounts for the negative impact of PNM2 on [PSI+]Sc4, but not on 
[PSI+]Sc37, propagation, we systematically tested the parameters that affect each step in the 
prion replication cycle (Fig. 2): fiber growth; fiber division, of which fiber stability and 
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ability to interact with the in vivo chaperone prion-replication machinery are key 
determinants; and delivery of prion particles to daughter cells during cell division.
PNM2 disrupts Sc37 growth rate and structural stability
To determine whether changes in fiber growth rates account for the observed phenotypic 
differences, we compared in vitro growth rates of WT and PNM2 fibers. While earlier 
studies found that PNM2 fibers have a partial growth defect, the nature of the prion strain 
variants in these studies was not well defined27. For our studies, we used a fragment of 
Sup35p (SupNM; residues 1–254, containing the Q/N-rich N-terminal and highly charged 
middle domains of Sup35p) that is necessary and sufficient to support prion 
propagation28,29. The seeded polymerization rates of soluble SupNM were monitored by 
measuring the increase in fluorescence intensity of Thioflavin T. We found that when 
seeded, PNM2 SupNM polymerizes into the Sc37 conformation at a rate slower than that 
observed with WT SupNM (Fig. 3). Since this change in growth rate would be predicted to 
weaken the prion phenotype, other mechanisms must account for the similar phenotype of 
PNM2 and WT in the Sc37 conformation.
A PNM2-induced change in amyloid structure could explain the change in Sc37 fiber 
growth rate as well as provide insight into prion division rates in vivo16. Therefore, we used 
a range of biophysical techniques, including hydrogen/deuterium (H/D) exchange NMR, 
fiber thermal denaturation, and propensity for shearing to produce new fiber seeds, to 
analyze the structure and stability of PNM2 SupNM fibers. Shearing efficacy was 
determined by the ability of long fibers fragmented via stirring to seed monomer growth as 
measured from the initial polymerization rates of such reactions.
For the H/D exchange experiments, we monitored the extent of backbone amide exchange 
for both WT and PNM2 fibers at two different time points: after a short exchange period of 
2 minutes and after a more extensive exchange period of 1 day. Based on previous 
assignments15, we measured exchange for 132 residues, including extensive probes 
throughout the amyloid core of both the Sc4 and Sc37 conformations.
The H/D exchange experiments revealed that the PNM2 mutation induced specific, localized 
structural defects in the Sc37 conformation. Specifically, we observed a region of increased 
exchange in residues proximal to the site of the PNM2 mutation for both early and late 
exchange time points (Fig. 4a,b). Consistent with this result, we observed a decrease in the 
thermal stability of PNM2 SupNM Sc37 fibers (Tm = 80 °C ± 2) compared to WT SupNM 
Sc37 fibers (Tm = 86 °C ± 2) (Fig. 3c,d). Additionally, when subjected to shearing forces, 
PNM2 SupNM Sc37 fibers fragmented more than WT SupNM Sc37 fibers (Fig. 3e). These 
results suggest that the PNM2 mutation in the Sc37 conformation causes a localized 
structural destabilization with a resulting decrease in fiber stability.
The affects of the PNM2 mutation on Sc37 fibers may have opposing consequences for 
prion propagation. The localized structural defect would be expected to enhance the rate of 
prion division in vivo, causing an increase in the rate of generation of free fiber ends and 
subsequently strengthening the prion phenotype15,16. In contrast, the decrease in fiber 
growth would be expected to reduce monomer addition onto fibers and weaken the prion 
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phenotype. Therefore, we hypothesize that the modest overall effect of the PNM2 mutation 
on the [PSI+]Sc37 phenotype is the result of compensatory changes.
PNM2 does not affect Sc4 growth, stability or structure
To determine the mechanism by which the PNM2 mutation interferes with [PSI+]Sc4 
propagation, we carried out a set of experiments on Sc4 fibers analogous to those done on 
the Sc37 conformation. When seeded by Sc4, PNM2 SupNM polymerizes into the Sc4 
conformation at a rate similar to WT SupNM indicating that the negative effect of the PNM2 
mutation on [PSI+]Sc4 propagation cannot be explained by a decrease in fiber growth rate 
(Fig. 3a,b). The Sc4 fiber structure was also unaffected by the PNM2 mutation: H/D 
exchange experiments showed no appreciable differences between WT SupNM and PNM2 
SupNM fibers in the Sc4 conformation (Fig. 4c,d). Both the regions of protection and the 
extent of protection for all residues was virtually indistinguishable between the two samples 
for both short and long exchange times, suggesting that the structures were stable as well as 
very similar. Consistent with the above results, the melting temperatures of WT SupNM and 
PNM2 SupNM in the Sc4 conformation were comparable (77 °C ± 2 and 77 °C ± 5, 
respectively) (Fig. 3c,d). Lastly, when subjected to shearing forces, both PNM2 SupNM and 
WT SupNM fragmented to a similar extent (Fig. 3e).
Taken together, these results argue that PNM2 SupNM is able to polymerize into fibers with 
growth, structure and stability indistinguishable from that of WT Sc4 fibers, and that the 
defect in [PSI+]Sc4 propagation cannot be explained by the biophysical properties of the 
fibers.
PNM2 does not affect Sc4-chaperone interactions
Prion propagation is critically dependent on the host chaperone machinery, and in particular 
on Hsp104p26. A growing body of evidence indicates that Hsp104p acts in concert with 
Ssa1p (Hsp70) and Sis1p (Hsp40) to divide prion particles and therefore facilitate prion 
replication30–33. Specifically, Ssa1p and Sis1p bind to prion particles and deliver them to 
Hsp104p, which is thought to extract prion particles from fibers in an ATP-dependent 
process that involves translocation of the extracted monomers through its axial pore34. In 
addition to its role in propagation, Hsp104p also causes curing of the prion (i.e., conversion 
from [PSI+] to [psi−]) when expressed at high levels via a mechanism separate from fiber 
division. Therefore, the overall effect of Hsp104p is a balance between fiber division 
necessary for propagation at low levels and curing at high levels26. Since a fiber’s 
differential susceptibility to fragmentation and curing by Hsp104p can directly affect its 
propagation, we sought to evaluate whether changes in chaperone-prion interactions cause 
the PNM2 phenotype.
One possible explanation for the interference in [PSI+]Sc4 propagation by the PNM2 
mutation is that it causes loss of [PSI+] through increased susceptibility to curing by 
Hsp104p. To explore this possibility, we used a truncated variant of Hsp104p that is missing 
its N-terminal domain, termed Hsp104ΔNTD35. When this variant is expressed from the 
endogenous HSP104 locus in the genome, it is fully active in [PSI+] propagation and can 
mediate thermotolerance, but does not cure [PSI+] with overexpression35 (Supplementary 
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Fig. 1a). We found that the defect in [PSI+] propagation in PNM2 is observed even in the 
strain expressing Hsp104ΔNTD establishing that the sectoring seen in PNM2 is not due to 
curing via the mechanism active with overexpression of Hsp104p (Fig. 5a).
An alternate hypothesis is that the PNM2 mutation causes increased susceptibility to the 
fiber division activity of Hsp104p leading to fiber resolubilization. To test this, we expressed 
HSP104 and hsp104ΔNTD from a CEN/ARS plasmid that leads to a 2 to 3-fold increase in 
expression. At this expression level, wild type Hsp104p destabilized [PSI+] while 
Hsp104ΔNTD did not (Fig. 5b) indicating that the destabilization must be due to the curing 
activity of Hsp104p and not over-fragmentation. Importantly, we find that overexpression of 
Hsp104ΔNTD did not enhance PNM2 sectoring arguing that PNM2 fibers are not overly 
susceptible to fragmentation and resolubilization by Hsp104p (Fig. 5b, Supplementary Fig. 
1b). These results are distinct from those of Serio and coworkers (NSMB This Issue), who 
found that the PNM2 mutation can lead to fiber destabilization and enhanced Hsp104p-
mediated fiber dissolution. The differences between the two studies likely results from 
differences in the prion strain conformations that were examined as Serio et al. observe 
dominant curing of [PSI+] when WT and PNM2 Sup35p are coexpressed whereas we find 
that the PNM2 phenotype is recessive in Sc4. Additionally, the fact that the PNM2 mutation 
destabilizes the fibers in those studies suggest that residue 58 is within the amyloid core of 
their strain conformation. Indeed we have generated examples of prion strain conformation 
that, like the Sc4 conformation lead to “strong” prion phenotypes, but nonetheless have 
amyloid cores that extend across residue 58 (unpublished data).
In an independent assay of Hsp104p activity, we looked at the size distribution of prion 
fibers by semi-denaturing detergent-agarose gel electrophoresis (SDD-AGE). Previous 
studies have shown that changes in Hsp104p activity affect aggregate size36 and that Sc37 
fibers, which are severed less efficiently by Hsp104p in vivo, are larger than those in the Sc4 
conformation16. We examined the relative sizes of Sc37 and Sc4 fibers and found that 
PNM2 and WT Sc4 fibers have the same size distribution (Fig. 5c). This finding is in 
agreement with our Hsp104ΔNTD data and indicates that PNM2 and WT Sc4 interact 
equally with Hsp104p.
Finally, to more directly look at interactions between Hsp104p and Sc4 fibers, we used a 
system developed to monitor the flux of substrates through the axial pore of Hsp104p (Fig. 
5d). Tessarz et al.34 and Tipton et al.33 engineered derivatives of Hsp104p (HAP and 4BAP, 
respectively) that interact with ClpP, a bacterial protein that forms a proteolytic chamber. 
When used in conjunction with a catalytically dead mutant of ClpP (ClpPtrap), substrates of 
Hsp104p are translocated through HAP and trapped in the ClpP chamber. Thus, following 
its induction in HAP-expressing yeast, ClpPtrap was affinity purified to identify Hsp104p 
substrates. Given that translocation through Hsp104p is likely to be the terminal event in an 
interaction between Sup35p and the chaperone machinery, defects in any aspect of this 
interaction would be expected to yield a difference in the flux of Sup35p through Hsp104p.
Previous studies have shown that Sup35p is delivered to ClpPtrap in a HAP-dependent 
manner, and HAP only translocates Sup35p into ClpPtrap in [PSI+] cells33,34. Moreover, 
substantially less Sup35p is trapped in the weak [PSI+]Sc37 strain than in the strong, and 
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more efficiently divided16, [PSI+]Sc4 strain33. We both confirmed that WT Sup35p was 
trapped in a [PSI+]-dependent manner (Fig. 5e), and found that the flux of PNM2 through 
Hsp104 was similar to WT when expressed as either the sole source of Sup35p or co-
expressed with WT (Fig. 5f,g). Therefore, in agreement with our Hsp104ΔNTD and SDD-
AGE data, the HAP/ClpPtrap system shows that PNM2 Sc4 fibers interact normally with the 
Hsp104p chaperone machinery necessary for propagation.
PNM2 causes a defect in Sc4 propagon partitioning
We investigated whether the PNM2 mutation causes a defect in delivery of [PSI+]Sc4 
infectious particles (propagons) to daughter cells during cell division using a method 
developed by Cox, Ness, and Tuite37. Briefly, corresponding pairs of mother and daughter 
cells are separated and grown in media containing guanidine, which reversibly inhibits 
Hsp104p38–40, such that the number of propagons remain fixed. As the cells divide, a point 
is reached at which there is no more than one propagon per cell. When Hsp104p function is 
restored by removal of guanidine, the number of [PSI+] colonies that arise from the mother 
versus the daughter reports on the relative number of propagons in each mother/daughter 
pair. Although this assay does not yield a quantitative measure of the absolute number of 
prion particles, it allows monitoring of relative propagon numbers and loss of [PSI+] by one 
of the partners.
Using the above assay for [PSI+]Sc4 cells expressing WT or PNM2 Sup35p, we found 
evidence of partitioning dysregulation in PNM2 [PSI+]Sc4 cells (Fig. 6a,b). The mild bias in 
the distribution of propagons toward the mother and positive correlation between the 
number of propagons in the mother and daughter WT [PSI+]Sc4 cells seen previously37,41 
was lost in PNM2 [PSI+]Sc4 cells. Strikingly, for a subset of pairs, the mother contained a 
large number of propagons while the daughter did not inherit any. In contrast, we did not 
observe any pairs in which the daughter had propagons, but the mother did not. The failure 
of propagons to partition into daughter cells accounts for the rapid appearance of red [psi−] 
sectors in PNM2 [PSI+]Sc4 yeast colonies.
Discussion
Our studies point to a critical role for prion conformation in modulating the effects of 
changes in the sequence of a prion protein on prion propagation. In the case of [PSI+]Sc37, 
the PNM2 mutation affects the structural and physical characteristics of the amyloid fibers 
in a manner that has compensatory effects on prion propagation resulting in a mild effect on 
prion propagation in vivo. A different picture, however, emerges from studying PNM2 in the 
context of [PSI+]Sc4, where the mutation does not affect the amyloid structure or chaperone-
mediated fiber division, but has a striking negative effect on propagation. The effect of 
PNM2 on [PSI+]Sc4 points to a critical role for the least understood step of [PSI+] 
propagation: the partitioning of prion particles. In PNM2 [PSI+]Sc4 yeast, we observed a 
pronounced defect in the delivery of aggregates to daughter cells. This finding highlights the 
question of how [PSI+] prion particles are delivered to daughter cells.
Past studies indicate that the observed mother bias in the allocation of [PSI+] particles is 
roughly consistent with differences in cell volume between the mother and the daughter, 
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suggestive of partitioning by passive diffusion41. Other studies point to the potential for 
more active mechanisms in the segregation of protein aggregates, including the active 
recruitment of cytosolic aggregates to specific loci42,43. Because the PNM2 mutation lies 
outside of the amyloid core of the Sc4 conformation, it could disrupt interactions between 
this region of the prion protein and host factors responsible for prion segregation.
In support of a role for host factors in prion particle partitioning, we carried out an unbiased 
genetic screen for high copy suppressors of the PNM2 phenotype, in which we identified 
multiple independent isolates of two genes, LSB3 and ART5, that when overexpressed 
minimized sectoring in PNM2 [PSI+]Sc4 yeast (Supplementary Fig. 2a,b, Supplementary 
Methods). Lsb3p interacts with Las17p as well as the Sla1p/End3p/Pan1p complex, both 
factors involved in the regulation of actin dynamics44–46. The actin cytoskeleton has 
previously been implicated both in transport of general protein aggregates between mother 
and daughter cells42 as well as in the regulation of prion formation47,48. Art5p is primarily 
uncharacterized, but has proposed activity in the regulation of endocytosis49,50. While a full 
characterization of the role of these proteins in prion biology is beyond the scope of this 
study, it will be interesting to determine how prion particles are affected by actin-based 
transport and if endocytic pathways play a role in prion delivery to daughter cells.
Recent studies have suggested that size selection plays a vital role in prion particle 
transmission to daughter cells51. In this “size-based” model, the small prion particles, which 
are preferentially propagated to daughter cells, might be the species primarily affected by 
the PNM2 mutation such that these transmission-competent particles are either not delivered 
to daughter buds or actively retained in the mother cell. These possibilities may be related to 
the more general mechanism in which the cell specifically recognizes and concentrates 
misfolded protein aggregates42,43. Going forward, an understanding of the relationship 
between the cellular machinery for segregation of general protein aggregates and prion 
transmission is essential.
Our studies illustrate the importance of delivery of infectious proteins to daughter cells as a 
critical step in the [PSI+] propagation cycle. In the future, we anticipate that the [PSI+] 
system will prove useful for studying how cells survey, partition, and sequester protein 
aggregates. The PNM2 mutation in the Sc4 conformation should provide a critical tool for 
such studies, as it exhibits a distinct partitioning defect that is not confounded by changes in 
amyloid structure or chaperone-mediated fiber division.
Materials and Methods
Strains and plasmids
All strains were converted to [PSI+] by infection with in vitro formed Sc4 or Sc37 fibers. 
See Supplementary Information Tables 1 and 2 for full list of strains and plasmids.
Fiber preparation
Fibers were produced as described previously, using bacterially produced pure SupNM 
proteins carboxy-terminally tagged with 7x-histidine52.
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In vivo yeast prion propagation characterization
YJW1110 and YJW1111 were transformed with a LEU2-marked plasmid expressing WT or 
PNM2 from the endogenous promoter (pRS315 WT Sup35p or pRS315 PNM2 Sup35p, 
respectively). The resulting transformants were selected on media lacking uracil and leucine 
(SD–Ura–Leu), then subsequently passaged on YEPD, then 5-FOA, then 1/4 YEPD. For the 
swap back experiment, the [PSI+]Sc4 yeast background containing the pRS315 PNM2 
Sup35p plasmid was transformed with the original pRS316 WT Sup35p plasmid. Resulting 
transformants were selected on SD–Ura–Leu. After passaging several times on SD–Ura, 
colonies that required leucine for growth were identified. The [PSI+] phenotype was 
determined by observing the color on low adenine media (1/4 YEPD). The degree of 
sectoring, or loss of [PSI+], was determined by growing cultures in YEPD liquid media for 
24 hours at 30 °C and plating onto 1/4 YEPD plates at a density of ~400 colonies per plate. 
The number of [PSI+] and [psi−] colonies were then counted.
In vitro analysis of the physical properties of strain conformations
Fiber growth rates15, thermal stabilities8, and susceptibility to shearing16 were all 
determined as described previously.
H/D exchange NMR
Uniformly 15N labeled SupNM was expressed in E. coli and purified as previously 
described15. 15N-SupNM seeded fibers of each strain were made as described15 and 
concentrated to 1/25th of their original volume. The fibers were then diluted 1:10 into D2O 
buffer at pH 7.0 to begin the exchange. After the desired time, exchange was quenched by 
adjusting the pH to 2.5, and fibers were centrifuged at 100,000g for 25 min. The pellet was 
washed once with 5mM DCl in D2O, then centrifuged again at 100,000g for 20 min. The 
pellet was frozen, freeze-dried and stored at −80 °C until NMR acquisition. The NMR 
spectra were acquired as described previously15. Estimated minimum peak intensity was 
calculated by averaging the intensity of a set of fully exchanged residues.
In vivo analysis of Hsp104p activity using the variant Hsp104ΔNTD
The Hsp104p variant Hsp104ΔNTD, first constructed by Hung and Masison35, has the 
nucleotides corresponding to the N-terminal 146 residues deleted. hsp104ΔNTD was 
amplified and fused to the NAT cassette by PCR, and inserted into the HSP104 genomic 
locus of YJW1110 by homologous recombination, resulting in strain YJW1667. Plasmids 
pRS399 Hsp104p and pRS399 Hsp104ΔNTD35 were used to mildly (2–3 fold) overexpress 
Hsp104p or Hsp104ΔNTD. pRS399 is a pRS315 plasmid where the LEU2 marker has been 
replaced by a KanR cassette. Plasmids were transformed into YJW1110 and plated on 1/4 
YEPD containing the antibiotic G418 for visualization of the [PSI+] phenotype.
Semi-Denaturing Detergent-Agarose Gel Electrophoresis (SDD-AGE)
Relative aggregate size was determined by SDD-AGE as previously described53,54. Sup35p 
was probed for by western blotting using polyclonal anti-SupNM.
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ClpPtrap Affinity Purification Experiments
The ClpPtrap affinity purification experiments were performed as described previously34. 
Briefly, YJW1112, YJW1113, YJW1114, or YJW1115 that had been transformed with 
pRS313 WT Sup35p, pRS313 PNM2 Sup35p, pRS313 WT Sup35HA, or pRS313PNM2 
Sup35HA were grown in SD media with 50 μM CuSO4 from OD600 = 0.1 to 1 and lysed at 
4 °C by bead beating in IP buffer (50 mM Tris/Cl pH 8.0, 1 M NaCl, 2 mM EDTA, 0.5% 
(v/v) Triton X-100, 5 mM β-mercaptoethanol, + Roche Complete Protease Inhibitor 
Cocktail). The lysate was cleared by centrifugation at 15,000g for 15 min, incubated with 
Streptavidin Sepharose (GE Healthcare) at RT for 1 hr, washed with 40 column volumes of 
IP buffer, and eluted in IP buffer + 150 mM NaCl and 4 mM biotin. The eluate was 
subjected to SDS-PAGE and Sup35p was probed for by western blotting using polyclonal 
anti-SupNM.
Mother/Daughter propagon counting
The propagons in mothers and daughters were counted as described previously37. Briefly, 
mothers and daughters of YJW1110 (containing pRS315 WT Sup35p or pRS315 PNM2 
Sup35p as the sole source of Sup35p) were separated by micromanipulation onto YEPD 
plates containing 3mM Guanidine HCl. After growing at 30 °C for about 40 hours, whole 
colonies were isolated using a cut pipette tip, resuspended in a small volume of H2O, and 
plated onto SD–Ade + 5% (w/v) YEPD. After growing at 30 °C for 10 to 14 days, the 
number of [PSI+] colonies was counted. For the WT samples, [PSI+] colonies were easily 
distinguished from [psi−] and Ade revertants by color. The PNM2 samples contained 
background indistinguishable from true [PSI+] colonies by color. We estimated the average 
background by repeating the experiment using a [psi−] PNM2 strain created by curing the 
[PSI+]Sc4 PNM2 strain by successive passaging on YEPD containing 3 mM guanidine HCl. 
The average background of ~25 colonies per sample was subtracted for all counted values.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterization of in vivo prion phenotypes
(a) Expression levels of WT or PNM2 expressed from a plasmid in a [PSI+]Sc4 background. 
Expression levels were quantitated by immunoblotting with a polyclonal anti-SupNM 
antibody. Values represent the mean ± s.d. for three experiments. (b) Representative in vivo 
prion phenotypes of yeast spotted on low adenine media. WT Sup35p was replaced with 
(left panel), or was co-expressed with (middle panel) either WT or PNM2. (c) Enlarged view 
of the edge of the yeast spot. Presence of red sectors in [PSI+]Sc4 PNM2 indicates a loss of 
[PSI+]. (d) Quantification of loss of [PSI+] as determined by counting the number of [psi−] 
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colonies after growing for 24 hours in YEPD. Values represent the mean ± s.d. for three 
experiments. (e) Representative in vivo prion phenotypes of yeast spotted on low adenine 
media. WT Sup35p was replaced with PNM2, which was subsequently replaced with WT 
through plasmid exchanges.
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Figure 2. 
Schematic of the prion propagation cycle that includes (1) fiber growth, (2) chaperone 
mediated division, and (3) partitioning to daughter cells.
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Figure 3. 
Characterization of the physical properties of fibers formed in vitro.
(a) A representative experiment monitoring the relative growth rates of WT and PNM2 
SupNM. Polymerization of SupNM was performed with 5% (w/w) WT seed of the specified 
conformation, and the rate of addition of SupNM monomers was monitored by Thioflavin T 
fluorescence. Data were normalized to initial and final intensities. (b) The growth rates of 
Sc4 and Sc37 PNM2 SupNM normalized to those of WT SupNM polymerized on the 
relevant seed. Initial time points were fitted to a line and the slope (initial growth rate) was 
calculated. Values represent the mean ± s.d. for three experiments. (c,d) Thermal stability of 
WT and PNM2 fibers in Sc4 and Sc37 conformations. WT and PNM2 SupNM fibers in the 
Sc4 or Sc37 conformations were incubated at increasing temperatures, and samples were 
subjected to SDS-PAGE. Band intensities (susceptibility of aggregates to thermal 
solubilization) were plotted against temperature and fitted to a sigmoidal function. (e) 
Relative seeding efficacy of WT or PNM2 fibers in the Sc4 or Sc37 conformation before 
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and after stirring for 30 or 60 min. Seeding efficacy was determined by monitoring the 
initial fiber growth rates of polymerization reactions using stirred samples as seeds. Values 
represent mean ± s.e.m. for three experiments.
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Figure 4. 
H/D exchange of WT and PNM2 SupNM fibers. Intensities for assigned and unambiguous 
peaks corresponding to residues 1–141 were plotted as the fraction of the non-exchanged 
intensity after 2 min (a, c) and 1 day (b, d) of exchange for both WT (blue) and PNM2 (red) 
fibers in the Sc37 (a, b) and Sc4 (c, d) conformations. Unassigned and ambiguous residues 
are not displayed. The gray line represents the estimated minimum peak intensity following 
complete exchange.
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Figure 5. 
PNM2 fibers in the Sc4 conformation interact with the in vivo chaperone machinery. (a) 
HSP104 (top row) and hsp104ΔNTD (bottom row) were expressed in [PSI+]Sc4 yeast 
expressing either WT (left) or PNM2 (right) Sup35p and spotted onto low adenine media. 
(b) HSP104 and hsp104ΔNTD were expressed at increased levels along with endogenous 
Hsp104p in [PSI+]Sc4 yeast expressing WT or PNM2 Sup35p. “Vector only” denotes 
transformation with an empty CEN/ARS plasmid. (c) SDD-AGE analysis of prion particle 
size in duplicate from lysates of [PSI+]Sc4 (lanes 1–2 and 5–6), [PSI+]Sc37 (lanes 3–4) and 
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PNM2 [PSI+]Sc4 (lanes 7–8). SUP35 is genomic in lanes 1–4 and on a plasmid in lanes 5–8. 
Yeast express wild type HSP104 in all lanes. (d) Schematic of the in vivo HAP/ClpPtrap 
reaction. (e) Representative blot of the ClpPtrap affinity purification. WT Sup35p and 
ClpPtrap were expressed in backgrounds that were [PSI+]Sc4 or [psi−] expressing HAP or 
Hsp104p. (f) Monitoring the translocation of PNM2. HAP and ClpPtrap were expressed in 
[PSI+]Sc4 cells that also expressed WT or PNM2 Sup35p. Intensities of Sup35p elution 
signal from western blot (top panel) were normalized for input signal (bottom panel). (g) 
Monitoring translocation of PNM2 when co-expressed with WT. As in (f), but untagged WT 
Sup35p was also expressed in cells expressing HA-tagged WT or PNM2 Sup35p. The 
higher molecular weight band corresponds to HA-tagged Sup35p. Intensities of tagged-
Sup35p elution signals were normalized for input signal and for untagged-Sup35p elution 
signal. For Sup35 intensity, values are expressed as mean ± s.e.m for three experiments.
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Figure 6. PNM2 in the Sc4 conformation shows a defect in partitioning
The number of propagons in the daughter was plotted against number of propagons in the 
mothers for both WT (a) and PNM2 (b) [PSI+]Sc4 backgrounds. Red dots represent mother/
daughter pairs in which the mother contained propagons, but the daughter did not.
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